Navigation Links
Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
Date:9/15/2010

HAYWARD, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Leonard C. DeBenedictis, 69, Chief Technology Officer and a member of the company's board of directors, will retire from Solta Medical on October 1, 2010. Mr. DeBenedictis will be available to advise the company through the end of the year and he plans to remain active in the development of other emerging medical technologies.

Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. said, "Len has dedicated more than 45 years to the evolution of the laser industry and for the past decade was the driving force behind the breakthrough proprietary technology in our Fraxel® family of lasers. He joined us in 2008 with our acquisition of Reliant Technologies where Len was co-founder and CTO. In his tenure at Solta Medical, Len's leadership resulted in Solta's flagship product for fractional skin resurfacing, the Fraxel re:store® DUAL. In addition, Len has been a key player in forging our personal care product initiative with Philips Consumer Lifestyle and leaves us with an impressive pipeline of innovative products. I want to thank him for all of his contributions to the company."

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's three premier brands: Thermage®, Fraxel® and Isolaz®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. RetireSafe Announces Intention to Key Vote Senator Dorgans Drug Importation Amendment (SA 2793)
2. RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgans Drug Importation Plan Puts Seniors at Risk
3. AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer
4. Quinton Oswald Named Chief Executive Officer of SARcode Corporation
5. ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer
6. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
7. SL Industries Names Louis J. Belardi Chief Financial Officer
8. Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC
9. Former Singapore EDB Officer, Chew Hwee Yong, Joins Menicon as Chief of Special Projects as Menicon Accelerates its Globalization
10. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
11. Millennium Laboratories Announces New Chief Operating Officer David Cohen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):